ANTIARRHYTHMIC ACTIONS OF DL-SOTALOL IN VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS

被引:15
作者
SINGH, BN
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,WADSWORTH VET ADM HOSP,SCH MED,CARDIOVASC RES LAB,LOS ANGELES,CA 90073
关键词
DL-SOTALOL; EXPERIMENTAL FINDINGS; HEMODYNAMIC FINDINGS; SUPRAVENTRICULAR ARRHYTHMIAS; VENTRICULAR ARRHYTHMIAS;
D O I
10.1097/00005344-199220002-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
DL-Sotalol is a unique antiarrhythmic agent combining potent beta-blocking properties with the propensity to prolong cardiac repolarization in all myocardial tissues. Its beta-blocker-associated negative inotropic effects are attenuated by its action potential-lengthening effect. The drug has an elimination half-life of 10-15 h. Sotalol's major electrophysiologic profile constitutes the summed effects of beta-blockade and prolonged repolarization. It exerts a potent antifibrillatory action modulated by its antiadrenergic effects. The effectiveness and tolerance of sotalol in a variety of atrial and ventricular dysrhythmias is reviewed in the present article.
引用
收藏
页码:S75 / S90
页数:16
相关论文
共 112 条
[51]   TORSADE DE POINTES INDUCED BY SOTALOL DESPITE THERAPEUTIC PLASMA SOTALOL CONCENTRATIONS [J].
KRAPF, R ;
GERTSCH, M .
BRITISH MEDICAL JOURNAL, 1985, 290 (6484) :1784-1785
[52]  
LAAKSO M, 1981, LANCET, V2, P1168
[53]  
LAAKSO M, 1981, ANN CLIN RES, V13, P439
[54]  
LAAKSO M, 1981, EUROPEAN HEART J, V2, P355
[56]  
LEWIS M J, 1983, European Journal of Pharmacology, V86, P71
[57]   COMPARATIVE EFFICACY OF ORAL SOTALOL AND PROCAINAMIDE IN PATIENTS WITH CHRONIC VENTRICULAR ARRHYTHMIAS - A MULTICENTER STUDY [J].
LIDELL, C ;
REHNQVIST, N ;
SJOGREN, A ;
YLIUOTILA, RJ ;
RONNEVIK, PK .
AMERICAN HEART JOURNAL, 1985, 109 (05) :970-975
[58]  
LISH PM, 1967, CURR THER RES CLIN E, V9, P311
[59]  
LISH PN, 1985, J PHARMACOL EXP THER, V149, P161
[60]  
LLOYD EA, 1988, S AFR MED J, V74, P5